-
Apollo Hospitals
6,900.70 5,690.80(%) -
Waaree Energies
2,590.20 1,808.65(%) -
Reliance Industr
1,288.00 1,115.55(%) -
SpiceJet
55.49 79.90(%) -
Axis Bank
1,145.75 934.00(%) -
Dixon Technolog.
16,092.55 7,935.00(%) -
Suzlon Energy
56.78 37.95(%) -
Vodafone Idea
7.44 6.60(%) -
SBI Life Insuran
1,763.00 1,935.00(%) -
Tata Motors
651.45 542.55(%) -
Bharat Electron
293.70 221.00(%) -
Tata Power Co.
382.00 326.25(%) -
Reliance Power
40.91 23.26(%) -
Eternal Ltd
226.95 146.85(%) -
HDFC Bank
1,891.90 1,430.15(%) -
Jio Financial
249.15 198.60(%) -
Mazagon Dock
2,585.00 1,046.00(%) -
Adani Energy Sol
907.00 588.25(%) -
Nip. India Nifty
266.61 242.12(%) -
Adani Green
904.00 758.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Dr Lal Pathlabs Ltd Healthcare
- Indian Private
- BSE Code : 41261.0
- ISIN : INE600L01024
-
Today’s Low
2,723.30 -
Today’s High
2,979.00

-
Open
2,837.00 -
Perv Close
2,788.20 -
52W Low
2,201.20 -
52W High
3,653.95
Key Indicators
-
P/E(TTM)
52.58
-
Mar.Cap (₹Cr.)
24,335.23
-
Div & Yield %
0.83
-
Book Value(₹)
248.15
-
Debt-Equity Ratio
4.41
-
AGM Date
25-Apr-2025
-
EPS
55.28
-
P/E Ratio
52.58
Financials Ratios
-
Debt-Equity Ratio
0.19
-
Mar.Cap (₹Cr.)
24,335.23
-
RONW (%)
20.61
-
ROCE (%)
25.58
Score Board
-
Equity (₹ in Cr.)
83.59
-
BV (₹)
248.10
-
Sales( ₹ in Cr.)
1,966.76
-
NP (in Cr.)
384.13
-
NP Var(%)
32.0
-
Div%
180.0
-
CPS (₹)
55.10
-
EPS (₹)
46.00
-
Traded Value (₹ in Lakhs)
24,296.36
-
52 Week High
3,653.95
-
52 Week Low
2,201.20
-
Price BSE
2907.0
-
Price NSE
2,911.00
-
Market Capital( in Cr.)
24,296.36
-
P/C Ratio
52.80
-
P/E Ratio
63.30
-
Price Vs.BV
46.00
-
25-Apr-2025( 03:23)
Corporate News - Board... - Dr. Lal PathLabs announced tha...
-
25-Apr-2025( 03:23)
Corporate News - Dr. L... - Dr. Lal PathLabs announced tha...
-
25-Apr-2025( 02:47)
Results - Announcements - Dr La... - Net profit of Dr Lal Pathlabs...
-
19-Apr-2025( 10:39)
Corporate News - Dr. L... - Dr. Lal PathLabs will hold a m...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 1,966.76 | 1,769.03 | 1,878.79 | 1,490.56 | 1,273.60 | 1,164.90 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 1,966.76 | 1,769.03 | 1,878.79 | 1,490.56 | 1,273.60 | 1,164.90 |
Other Income | 60.11 | 46.60 | 53.10 | 51.27 | 57.61 | 46.49 |
Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Income | 2,026.87 | 1,815.63 | 1,931.89 | 1,541.83 | 1,331.21 | 1,211.39 |
EXPENDITURE : | ||||||
Raw Materials | 390.76 | 389.64 | 447.65 | 373.90 | 286.87 | 254.96 |
Power and Fuel Cost | 21.54 | 21.31 | 19.66 | 17.18 | 15.65 | 14.65 |
Employee Cost | 363.59 | 315.50 | 321.44 | 257.44 | 232.07 | 201.86 |
Other Manufacturing Expenses | 376.33 | 344.15 | 336.38 | 243.96 | 212.40 | 187.49 |
Selling and Administration Expenses | 209.38 | 196.57 | 196.04 | 152.52 | 161.60 | 185.67 |
Miscellaneous Expenses | 45.93 | 41.17 | 45.16 | 38.18 | 37.20 | 37.47 |
Employee Benefit Expenses | 363.59 | 315.50 | 321.44 | 257.44 | 232.07 | 201.86 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 1,407.52 | 1,308.33 | 1,366.32 | 1,083.18 | 945.79 | 882.10 |
Operating Profit | 619.35 | 507.30 | 565.57 | 458.65 | 385.42 | 329.29 |
Interest | 26.84 | 34.38 | 28.63 | 14.83 | 14.66 | 0.74 |
Gross Profit | 592.51 | 472.92 | 536.94 | 443.82 | 370.76 | 328.55 |
Depreciation | 76.54 | 82.09 | 75.94 | 69.78 | 68.01 | 36.18 |
Profit Before Tax | 515.97 | 390.83 | 461.00 | 374.04 | 302.75 | 292.37 |
Current Tax | 137.58 | 101.44 | 118.42 | 98.43 | 80.25 | 100.54 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -5.98 | -2.97 | -2.68 | -4.49 | -0.67 | -3.62 |
Reported Net Profit | 384.37 | 292.36 | 345.25 | 280.11 | 223.18 | 195.44 |
Extraordinary Items | 0.24 | 1.11 | 0.20 | -0.13 | 0.11 | 0.05 |
Adjusted Net Profit | 384.13 | 291.25 | 345.05 | 280.24 | 223.07 | 195.39 |
Adjustment below Net Profit | -0.27 | 1.94 | -1.32 | -0.71 | -6.72 | -6.76 |
P & L Balance brought forward | 1,378.66 | 1,183.79 | 955.56 | 773.56 | 704.92 | 565.80 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 199.48 | 99.43 | 115.71 | 99.11 | 147.82 | 49.56 |
P & L Balance carried down | 1,563.28 | 1,378.66 | 1,183.79 | 953.84 | 773.56 | 704.92 |
Dividend | 149.65 | 49.72 | 115.71 | 99.11 | 98.93 | 20.59 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 180.00 | 60.00 | 120.00 | 200.00 | 120.00 | 60.00 |
Dividend Per Share(Rs) | 18.00 | 6.00 | 12.00 | 20.00 | 12.00 | 6.00 |
Earnings Per Share-Unit Curr | 46.04 | 35.07 | 41.42 | 33.61 | 26.78 | 23.45 |
Earnings Per Share(Adj)-Unit Curr | 46.04 | 35.07 | 41.42 | 33.61 | 26.78 | 23.45 |
Book Value | 227.56 | 202.70 | 176.63 | 146.03 | 124.83 | 115.02 |
Book Value(Adj)-Unit Curr | 227.56 | 202.70 | 176.63 | 146.03 | 124.83 | 115.02 |